Moreover, the same inhibitor also demonstrated that inhibition of PRMT5 significantly reduced gemcitabine resistance in pancreatic cancer caused by UBR7 depletion (Table 4) (Bi et al., 2023). The gene discussed is UBR7; the disease is familial pancreatic carcinoma.